Low-Dose Berberine Attenuates the Anti-Breast Cancer Activity of Chemotherapeutic Agents via Induction of Autophagy and Antioxidation
Berberine (BBR), a major active component of Rhizoma coptidis , is one of the most promising agents for breast cancer adjuvant therapy. It is well accepted that BBR could exhibit remarkable anticancer efficacy with few side effects, and when treated with chemotherapeutic agents in combination, BBR c...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publishing
2020-10-01
|
| Serier: | Dose-Response |
| Online adgang: | https://doi.org/10.1177/1559325820939751 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|